The Chico Police Department (CPD) is looking to fill the next round of academy seats, offering paid training to serve the community. Online petition urges Shasta supervisors to remove county elections ...
Abstract: Class imbalance is a significant challenge in medical image analysis, particularly in lung ultrasound (LUS), where severe patterns are often underrepresented. Traditional oversampling ...
Travelers across the country are encountering extended wait times at airports as the Transportation Security Administration (TSA) manages staffing challenges due to a partial government shutdown. TSA ...
HOUSTON — Travelers flying out of William P. Hobby Airport on Sunday faced unusually long security lines, with some waits stretching four to five hours as spring break travel ramps up. Officials say ...
NEW ORLEANS — Travelers at Louis Armstrong New Orleans International Airport will need to pack extra patience as the airport is experiencing extremely long lines at the TSA security gate. Officials ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. John Zola stands in an apple tree grove on his ...
Background Ultrasound is now readily available in the prehospital setting and its use has been highlighted as one of the top research priorities in prehospital care. Clinical examination remains the ...
If you’re someone who hates hanging around in airports and tends to arrive as late as possible, these statistics might help make your next trip less panicky. Here, we’ve ranked the 10 U.S. airports ...
Abstract: Accurately identifying B-lines and pleural line (P-line) in lung ultrasound (LUS) videos is valuable for evaluating certain lung conditions. However, manual interpretation remains subjective ...
Bovine respiratory disease (BRD) remains one of the most common and costly health challenges in preweaned dairy calves. While traditional diagnosis relies on visual symptoms, such as coughing, nasal ...
Feb 26 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Boehringer Ingelheim's zongertinib as a first-line treatment for a rare form of non-small cell lung cancer, making it the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results